↓ Skip to main content

Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas

Overview of attention for article published in BMC Cancer, November 2010
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
156 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas
Published in
BMC Cancer, November 2010
DOI 10.1186/1471-2407-10-631
Pubmed ID
Authors

Ymera Pignochino, Ivana Sarotto, Caterina Peraldo-Neia, Junia Y Penachioni, Giuliana Cavalloni, Giorgia Migliardi, Laura Casorzo, Giovanna Chiorino, Mauro Risio, Alberto Bardelli, Massimo Aglietta, Francesco Leone

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 3%
Unknown 30 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 29%
Other 5 16%
Student > Master 4 13%
Student > Ph. D. Student 2 6%
Student > Bachelor 2 6%
Other 4 13%
Unknown 5 16%
Readers by discipline Count As %
Agricultural and Biological Sciences 12 39%
Biochemistry, Genetics and Molecular Biology 6 19%
Medicine and Dentistry 5 16%
Arts and Humanities 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 1 3%
Unknown 5 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 September 2018.
All research outputs
#8,279,450
of 24,777,509 outputs
Outputs from BMC Cancer
#2,294
of 8,772 outputs
Outputs of similar age
#57,716
of 190,622 outputs
Outputs of similar age from BMC Cancer
#20
of 52 outputs
Altmetric has tracked 24,777,509 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,772 research outputs from this source. They receive a mean Attention Score of 4.6. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 190,622 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.